Found: 68
Select item for more details and to access through your institution.
The Importance of Outcome and Precise Evaluation in Economic Analysis of Cancer Drugs.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Covid‐19: Time for a paradigm change.
- Published in:
- Reviews in Medical Virology, 2020, v. 30, n. 5, p. 1, doi. 10.1002/rmv.2134
- By:
- Publication type:
- Article
COVID-19 and Cancer: a Comprehensive Review.
- Published in:
- Current Oncology Reports, 2020, v. 22, n. 5, p. 1, doi. 10.1007/s11912-020-00934-7
- By:
- Publication type:
- Article
Optimal Practices for Suspected Nodal Melanoma—The Role of the General Surgeon.
- Published in:
- 2024
- By:
- Publication type:
- Opinion
Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2016, v. 23, n. 13, p. 4169, doi. 10.1245/s10434-016-5286-0
- By:
- Publication type:
- Article
Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma.
- Published in:
- Head & Neck, 2011, v. 33, n. 12, p. 1804, doi. 10.1002/hed.21478
- By:
- Publication type:
- Article
The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th–December 1st, 2022.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04117-3
- By:
- Publication type:
- Article
The "Great Debate" at Melanoma Bridge 2022, Naples, December 1st–3rd, 2022.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04100-y
- By:
- Publication type:
- Article
The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The "Great Debate" at Immunotherapy Bridge 2021, December 1st-2nd, 2021.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Targeting wild-type TP53 using AMG 232 in combination with MAPK inhibition in Metastatic Melanoma; a phase 1 study.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1051, doi. 10.1007/s10637-022-01253-3
- By:
- Publication type:
- Article
Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 1, p. 159, doi. 10.1007/s10637-014-0167-5
- By:
- Publication type:
- Article
B-RAF Inhibitors: An Evolving Role in the Therapy of Malignant Melanoma.
- Published in:
- Current Oncology Reports, 2010, v. 12, n. 3, p. 146, doi. 10.1007/s11912-010-0095-2
- By:
- Publication type:
- Article
Determination of chemically reduced pyrrolobenzodiazepine SJG-136 in human plasma by HPLC-MS/MS: application to an anticancer phase I dose escalation study.
- Published in:
- Journal of Mass Spectrometry, 2008, v. 43, n. 1, p. 42, doi. 10.1002/jms.1268
- By:
- Publication type:
- Article
New Does Not Always Mean Better: Isolated Limb Perfusion Still Has a Role in the Management of In-Transit Melanoma Metastases.
- Published in:
- Oncology (08909091), 2016, v. 30, n. 12, p. 1053
- By:
- Publication type:
- Article
Evaluation of the pharmacokinetic drug interaction potential of tivantinib (ARQ 197) using cocktail probes in patients with advanced solid tumours.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 112, doi. 10.1111/bcp.13424
- By:
- Publication type:
- Article
The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors †.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 4913, doi. 10.3390/cancers15204913
- By:
- Publication type:
- Article
Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems.
- Published in:
- Immunological Reviews, 1998, v. 165, n. 1, p. 47, doi. 10.1111/j.1600-065X.1998.tb01229.x
- By:
- Publication type:
- Article
A first-in-human phase I, multicenter, open-label, dose-escalation study of the oral RAF/VEGFR-2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 8, p. 1904, doi. 10.1002/cam4.1140
- By:
- Publication type:
- Article
Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204).
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1961, doi. 10.1093/neuonc/noab094
- By:
- Publication type:
- Article
Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response.
- Published in:
- Clinical Pharmacology, 2022, v. 14, p. 69, doi. 10.2147/CPAA.S369008
- By:
- Publication type:
- Article
Treatment of NRAS-Mutant Melanoma.
- Published in:
- Current Treatment Options in Oncology, 2015, v. 16, n. 4, p. 1, doi. 10.1007/s11864-015-0330-z
- By:
- Publication type:
- Article
Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy).
- Published in:
- 2018
- By:
- Publication type:
- research
The Great Debate at "Melanoma Bridge", Napoli, December 2nd, 2017.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.
- Published in:
- 2017
- By:
- Publication type:
- historical material
The need for a network to establish and validate predictive biomarkers in cancer immunotherapy.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
T-VEC Boosts Immunotherapy in Phase 1 Trials.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2017, v. 8, p. 41
- By:
- Publication type:
- Article
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy.
- Published in:
- Nature Communications, 2016, v. 7, n. 1, p. 10582, doi. 10.1038/ncomms10582
- By:
- Publication type:
- Article
Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd-3rd, 2020, Italy).
- Published in:
- 2021
- By:
- Publication type:
- journal article
The "Great Debate" at Immunotherapy Bridge 2020, December 3rd, 2020.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The "Great Debate" at Melanoma Bridge 2020: December, 5th, 2020.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge" (December 4th-5th, 2019, Naples, Italy).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature.
- Published in:
- Case Reports in Oncology, 2019, v. 12, n. 1, p. 260, doi. 10.1159/000498985
- By:
- Publication type:
- Article
Prostate cancer as a dedifferentiated organ: androgen receptor, cancer stem cells, and cancer stemness.
- Published in:
- Essays in Biochemistry, 2022, v. 66, n. 4, p. 291, doi. 10.1042/EBC20220003
- By:
- Publication type:
- Article
Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma.
- Published in:
- 2015
- By:
- Publication type:
- Abstract
Combining targeted and immunotherapy: BRAF inhibitor dabrafenib (D) ± the MEK inhibitor trametinib (T) in combination with ipilimumab (Ipi) for V600E/K mutation-positive unresectable or metastatic melanoma (MM).
- Published in:
- Journal of Translational Medicine, 2015, v. 13, p. 1, doi. 10.1186/1479-5876-13-S1-K8
- By:
- Publication type:
- Article
Blocking Immune Checkpoints in Metastatic Melanoma.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 5, p. 275
- By:
- Publication type:
- Article
Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses.
- Published in:
- Nature Communications, 2018, p. 1, doi. 10.1038/s41467-018-06067-7
- By:
- Publication type:
- Article
The efficacy of anti-PD-1 agents in acral and mucosal melanoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 17, p. 2684, doi. 10.1002/cncr.28767
- By:
- Publication type:
- Article
Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 24, p. 6055, doi. 10.1002/cncr.27668
- By:
- Publication type:
- Article
Combination Targeted Therapy in Advanced Renal Cell Carcinoma.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 10, p. 2368, doi. 10.1002/cncr.24234
- By:
- Publication type:
- Article
Alterations in osteoclast morphology following long-term 17betaestradiol administration in the mouse.
- Published in:
- BMC Cell Biology, 2001, v. 2, p. 3, doi. 10.1186/1471-2121-2-3
- By:
- Publication type:
- Article
A phase I trial of concurrent sorafenib and stereotactic radiosurgery for patients with brain metastases.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 2, p. 435, doi. 10.1007/s11060-017-2455-3
- By:
- Publication type:
- Article
Intratumoral Immunotherapy—Update 2019.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e423, doi. 10.1634/theoncologist.2019-0438
- By:
- Publication type:
- Article
Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation Sequencing Panel.
- Published in:
- Oncologist, 2014, v. 19, n. 6, p. 616, doi. 10.1634/theoncologist.2014-0011
- By:
- Publication type:
- Article